Monopar TherapeuticsMNPREarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Monopar Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative targeted therapies for cancer patients. Its lead product candidates address unmet oncology medical needs, serving North American markets and partnering with global healthcare and research institutions to advance its development pipeline.